Manufactured for Sciele Pharma, Inc., Atlanta, Georgia 30328 by G. Pohl-Boskamp GmbH & Co. KG, D-25551 Hohenlockstedt, Germany

Scroll down for Important Safety Information.

Contact Sciele Pharma, Inc.

Sciele Pharma, Inc. is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular/Diabetes, Women's Health and Pediatrics. The Company's Cardiovascular/Diabetes products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and Type 2 diabetes; its Women's Health products are designed to improve the health and well-being of women and mothers and their babies; and its Pediatrics products treat allergies, asthma, coughs and colds, and attention deficit/hyperactivity disorder (ADHD).

Founded in 1992 and headquartered in Atlanta, Georgia, Sciele Pharma employs more than 900 people. The Company's success is based on placing the needs of patients first, improving health and quality of life, and implementing its business platform - an Entrepreneurial Spirit, Innovation, Speed of Execution, Simplicity, and Teamwork.

Mailing Address:

Phone:
Customer Support

Medical Affairs:
(For Medical Information/
Adverse Events/ Product Complaints)

Sciele Pharma, Inc.
5 Concourse Pkwy.
Suite 1800
Atlanta, Georgia 30328

(800) 461-3696

(800) 849-9707 ext 1454

Indications and Usage: Nitrolingual Pumpspray is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.

Important Safety Information: Nitrolingual Pumpspray should not be used while taking phosphodiesterase inhibitors which are used for the treatment of erectile dysfunction. Nitrolingual Pumpspray should be used with caution if patients have low systolic blood pressure, are undergoing diuretic therapy, or show hypersensitivity to this and other nitrates or nitrites. Headache is the most commonly reported side effect with nitroglycerin. Patients may also experience episodes of dizziness, weakness, and other related side effects.

Safety and effectiveness of nitroglycerin in pediatric patients have not been established.

Click here for Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088

Nitrolingual is a registered trademark of G. Pohl-Boskamp GMBH & Co. Sciele's use of Nitrolingual is under license from G. Pohl-Boskamp GMBH & Co.

This web site and its contents are intended for use only by residents of the United States. Products discussed may have different labeling, regulatory requirements, and/or medical practices in other countries that may require reference to different or additional information.